PPA
ARLZ

Parametric Portfolio Associates’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Parametric Portfolio Associates’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-54,612
Closed -$82K – 4078
2018
Q1 		$82K Hold
54,612
– – ﹤0.01% 3870
2017
Q4 		$78K Buy
54,612
+16,263
+42% +$26.7K ﹤0.01% 3847
2017
Q3 		$88K Buy
+38,349
New +$51.3K ﹤0.01% 3958
2017
Q2 		– Sell
-37,907
Closed -$81K – 4126
2017
Q1 		$81K Buy
+37,907
New +$142K ﹤0.01% 3705

Other funds holding ARLZ

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
SM
Salzhauer Michael $292M AUM 30% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
SCP
Silverleafe Capital Partners Germantown, Tennessee $367M AUM 37.49% 1-Year Est. Return
FSA
Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Parametric Portfolio Associates's ARLZ Position: Q2 2018 in Review

Parametric Portfolio Associates sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q2 2018, closing a stake of 54,612 shares — an estimated $82K sold.

Parametric Portfolio Associates first reported a position in ARLZ in Q1 2017 and held it in 4 quarters. The position peaked at $88K in Q3 2017. 48 funds tracked by Wall St. Rank hold ARLZ as of Q2 2018.

  • Parametric Portfolio Associates reported no remaining Aralez Pharmaceuticals Inc. position as of Q2 2018 after selling out during the quarter.
  • Parametric Portfolio Associates sold 54,612 Aralez Pharmaceuticals Inc. shares in Q2 2018, an estimated $82K.
  • Parametric Portfolio Associates first reported a position in Aralez Pharmaceuticals Inc. in Q1 2017 and held it in 4 quarters.
  • Parametric Portfolio Associates's Aralez Pharmaceuticals Inc. position peaked at $88K in Q3 2017.
  • 48 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q2 2018.

Based on Parametric Portfolio Associates's 13F filing for Q2 2018, filed 13 Aug 2018.